Compare PDS & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PDS | BLFS |
|---|---|---|
| Founded | 1951 | 1987 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 923.5M |
| IPO Year | 1998 | 2013 |
| Metric | PDS | BLFS |
|---|---|---|
| Price | $88.75 | $25.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $122.33 | $32.00 |
| AVG Volume (30 Days) | 91.8K | ★ 519.2K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $5.66 | $19.73 |
| Revenue Next Year | $2.31 | $17.82 |
| P/E Ratio | ★ $884.15 | $1,273.75 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $43.50 | $17.86 |
| 52 Week High | $103.80 | $29.57 |
| Indicator | PDS | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 41.82 | 66.04 |
| Support Level | $87.74 | $23.74 |
| Resistance Level | $92.40 | $26.39 |
| Average True Range (ATR) | 3.18 | 1.10 |
| MACD | -0.72 | 0.28 |
| Stochastic Oscillator | 5.60 | 87.16 |
Precision Drilling Corp is a provider of contract drilling, completion, and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. The company operates through two industry segments: Contract Drilling Services, which generates maximum revenue and includes drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale, and repair of drilling equipment; and Completion and Production Services, which includes service rigs, oilfield equipment rental, and camp services. The company generates the majority of its revenue from the United States.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.